Lineage Cell Therapeutics
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Lineage Cell Therapeutics
Danone North America’s Activia video campaign “A-to-Z” targets young women to make a connection between emotions and the complexity of the gut microbiome. The campaign will include four videos, with the first promoting a “bright, fun and musical” feel on the branded site and on YouTube.
The $1.4bn deal will combine Invitae’s centralized laboratory capabilities with ArcherDX’s precision oncology technologies.
Private Company Edition: Arvelle, insitro, AbCellera and the University of Michigan have something in common – they each attracted more than $100m in venture capital investment.
The Swiss biotech's focal-onset seizure therapy, which is licensed from South Korea's SK and is already approved in the US, could have potential in indications beyond epilepsy, Arvelle's CEO tells Scrip.
- Research, Analytical Equipment & Supplies
- Drug Delivery
In Vitro Diagnostics
- Molecular Diagnostics & Genetic Testing
- Gene Therapy, Cell Therapy
Drug Discovery Tools
- Other Names / Subsidiaries
- Asterias Biotherapeutics, Inc.
- BioTime Acquisition Corp.
- BioTime, Inc.
- Cell Cure Neurosciences Ltd.
- Embryome Sciences
- ES Cell International Pte Ltd
- LifeMap Sciences, Inc.
- OncoCyte Corporation
- ReCyte Therapeutics